Maria Koehler
Technik-/Wissenschafts-/F&E-Leiter bei REPARE THERAPEUTICS INC.
Vermögen: 695 220 $ am 31.05.2024
Profil
Maria Koehler is currently an Independent Director at Ikena Oncology, Inc. and a Director at Abdera Therapeutics, Inc. She is also an Associate Professor at the University of Pittsburgh.
Previously, she served as the Chief Medical Officer & Executive Vice President at Repare Therapeutics, Inc. from 2019.
Prior to that, she held positions such as Senior Medical Director at AstraZeneca PLC from 1998 to 2005, Independent Director at Celyad Oncology SA and Silverback Therapeutics, Inc., and Director-Bone Marrow Transplant at UPMC Children's Hospital of Pittsburgh from 1997 to 1998.
She also worked as the VP-Strategy, Innovation & Collaborations at Pfizer Inc. from 2009 to 2017 and as the Chief Medical Officer at Bicycle Therapeutics Plc from 2017 to 2019.
Dr. Koehler holds a doctorate degree from the Medical University of Silesia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPARE THERAPEUTICS INC.
0,47% | 15.04.2024 | 199 776 ( 0,47% ) | 695 220 $ | 31.05.2024 |
IKENA ONCOLOGY, INC.
-.--% | 07.06.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Maria Koehler
| Unternehmen | Position | Beginn |
|---|---|---|
| REPARE THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 |
| IKENA ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 15.04.2021 |
| University of Pittsburgh | Corporate Officer/Principal | - |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Maria Koehler
| Unternehmen | Position | Ende |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 |
| PFIZER, INC. | Corporate Officer/Principal | 01.09.2017 |
| ASTRAZENECA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
St. Christopher's Hospital for Children LLC
 St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01.01.1998 |
| UPMC Children's Hospital of Pittsburgh | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von Maria Koehler
| Medical University of Silesia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| PFIZER, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| CELYAD ONCOLOGY SA | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
St. Christopher's Hospital for Children LLC
St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA. | Health Services |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
| UPMC Children's Hospital of Pittsburgh | |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |
